Heart Disease News and Research

Latest Heart Disease News and Research

Study finds young Australian staff sacked in sick circumstances

Some employers are exploiting the vulnerability of young unsupported workers, sacking them in unfair circumstances, a new study by Queensland University of Technology (QUT) has found.

13 Sep 2007

Vibrating catheters break through clogged arteries

A new vibrating catheter breaks through clogged arteries like a jackhammer, obliterating total blockages in patients with dangerous chronic total occlusions (CTOs).

13 Sep 2007

New technique detects how proteins undergo changes inside a cell

In the September issue of Molecular & Cellular Proteomics , scientists describe a new technique that can detect how proteins undergo changes inside a cell.

13 Sep 2007

Genetic link to loneliness

It's already known that a person's social environment can affect their health, with those who are socially isolated - that is, lonely suffering from higher mortality than people who are not.

13 Sep 2007

FDA committees recommend continued U.S. marketing for Trasylol

The Cardiovascular and Renal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee to the U.S. Food and Drug Administration (FDA) held a meeting to discuss the risk /benefit profile of Trasylol (aprotinin injection), a Bayer drug used in coronary artery bypass graft (CABG) surgery.

13 Sep 2007

Effects of diesel exhaust on heart and blood vessel function

Air pollution could be putting patients with heart disease at risk by affecting blood vessels and clotting, researchers warn

13 Sep 2007

New devices and trials for the treatment and prevention of dialysis access stenosis

Having a healthy kidney is worth a billion dollars. But an unhealthy kidney costs more - about $16 billion more, according to Prabir Roy-Chaudhury, MD, PhD, associate professor in the division of nephrology and hypertension at the University of Cincinnati (UC).

13 Sep 2007

Living, growing artificial heart-valve replacements for children

Infants and children receiving artificial heart-valve replacements face several repeat operations as they grow, since the since the replacements become too small and must be traded for bigger ones.

13 Sep 2007

New clues to cracking brain's neural code

Decoding the complex electrical signals that brain cells use to "talk" to each other is a new and important frontier in neuroscience, one that could revolutionize the diagnosis and treatment of neurological and psychiatric disease.

12 Sep 2007

Pocket guidelines for assessment and management of cardiovascular risk

A new book of pocket-charts that will help health workers to identify people at risk of heart attacks and strokes and save lives by prescribing the most appropriate treatment is published today by the World Health Organization (WHO). The charts can be adapted for use in any setting, in any country, with any patient.

12 Sep 2007

American life expectancy reaches an all-time high of 78

According to the Centers for Disease Control and Prevention (CDC), a child born in the United States in 2005 can expect to live nearly 78 years.

12 Sep 2007

Researchers question safety of Avandia and it's longterm use

Researchers in the U.S. say the long-term use of a medication used in patients with type 2 Diabetes and people with glucose intolerance, increases the risk for heart failure and heart attacks.

12 Sep 2007

Rochester receives $1.2 million to battle rare childhood disease

"For an orphan disease like Batten, which has such a clear-cut course of deterioration and no present cure, this grant is transformative both for these families and for us, as clinicians and researchers."

12 Sep 2007

Ultraconserved non-coding RNAs may be important in human cancer

Research here shows that an obscure form of RNA, part of the protein-making machinery in all cells, might play an important role in human cancer.

12 Sep 2007

Long-term use of rosiglitazone (Avandia) increases heart attack risk by more than 40 percent

An analysis of four studies involving more than 14,000 patients found that long-term use of the diabetes drug rosiglitazone (Avandia) increased the risk of heart attack by 42 percent and doubled the risk of heart failure, according to a new report from researchers at Wake Forest University School of Medicine and colleagues.

12 Sep 2007

Glycemic control medication appears to have favorable effect regarding risk of cardiovascular events

A meta-analysis of previous research suggests that use of pioglitazone, a glycemic control medication for patients with type 2 diabetes, significantly reduces the risk of heart attack, stroke and death, but increases the risk for serious heart failure, according to an article in the September 12 issue of JAMA: The Journal of the American Medical Association.

12 Sep 2007

GlaxoSmithKline responds to Journal of the American Medical Association articles

GlaxoSmithKline believes that conclusions drawn from the most recent meta-analyses published by Drs. Nissen et. al. and Furberg et. al. in the Journal of the American Medical Association do not confirm a difference in the safety profile of Avandia (rosiglitazone) and Actos (pioglitazone).

12 Sep 2007

Heart Disease News and Research

Latest Heart Disease News and Research

Study finds young Australian staff sacked in sick circumstances

Vibrating catheters break through clogged arteries

New technique detects how proteins undergo changes inside a cell

Genetic link to loneliness

FDA committees recommend continued U.S. marketing for Trasylol

Effects of diesel exhaust on heart and blood vessel function

New devices and trials for the treatment and prevention of dialysis access stenosis

Living, growing artificial heart-valve replacements for children

New clues to cracking brain's neural code

Pocket guidelines for assessment and management of cardiovascular risk

American life expectancy reaches an all-time high of 78

Researchers question safety of Avandia and it's longterm use

Rochester receives $1.2 million to battle rare childhood disease

Ultraconserved non-coding RNAs may be important in human cancer

Long-term use of rosiglitazone (Avandia) increases heart attack risk by more than 40 percent

Glycemic control medication appears to have favorable effect regarding risk of cardiovascular events

GlaxoSmithKline responds to Journal of the American Medical Association articles

Generic prostate drug finasteride helps find high-risk cancers early

Embryonic stem cell strategy advanced with UCSF finding

Carvedilol used for treatment for heart failure in adults may not be beneficial for children and teens

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Heart Disease News and Research

Latest Heart Disease News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in